Search

everythinglearnresearchcommunity

for

Search:↓

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Mice with autoimmune hair loss showed signs of heart problems.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Women with early onset androgenetic alopecia have worse lipid profiles.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Vitiligo is influenced by genetics and environment, and combining these factors can improve early detection and prevention.

Vimentin is crucial for wound healing, cell growth, and managing immune responses.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.

Type 1 diabetes may cause certain autoimmune diseases in Europeans.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

New therapies for alopecia areata show potential but need more research.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

Statins may help treat alopecia areata by reducing harmful immune interactions.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

Clonally expanded CD8+ T cells cause alopecia areata.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.